Search alternatives:
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
-
3401
S12 Data -
Published 2025“…A comprehensive evaluation and correlation analysis of each cold tolerance index and the expression of the <i>VcCBF3</i> gene revealed that a treatment concentration of 0.4 mg·L<sup>-1</sup> had the most significant mitigating effect among the sprayed EBR concentrations of 0, 0.2, 0.4, 0.6, and 0.8 mg·L<sup>-1</sup>.…”
-
3402
-
3403
-
3404
-
3405
-
3406
-
3407
Flow chart.
Published 2025“…</p><p>Conclusions</p><p>CPE can have a significant impact on body awareness, leading to a decrease in the ability to perceive one’s own body. …”
-
3408
Demographic characteristics of the participants.
Published 2025“…</p><p>Conclusions</p><p>CPE can have a significant impact on body awareness, leading to a decrease in the ability to perceive one’s own body. …”
-
3409
Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i>
Published 2025“…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”
-
3410
NIE ELISA results.
Published 2025“…</p><p>Hookworm prevalence at baseline was 78% (91/117) and 80% (119/149) in villages assigned to DA and IDA treatment, respectively. Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
3411
Kato Katz and PCR database 12 months collection.
Published 2025“…</p><p>Hookworm prevalence at baseline was 78% (91/117) and 80% (119/149) in villages assigned to DA and IDA treatment, respectively. Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
3412
Master database baseline, 4 weeks and 1 year.
Published 2025“…</p><p>Hookworm prevalence at baseline was 78% (91/117) and 80% (119/149) in villages assigned to DA and IDA treatment, respectively. Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
3413
-
3414
-
3415
-
3416
-
3417
-
3418
-
3419
-
3420